Support for Small Business Innovation Research to Develop New Open and Closed-Loop Automated Technologies for Better Type 1 Diabetes Therapy and Monitoring (SBIR) (R43/R44- Clinical Trial Not Allowed)

The summary for the Support for Small Business Innovation Research to Develop New Open and Closed-Loop Automated Technologies for Better Type 1 Diabetes Therapy and Monitoring (SBIR) (R43/R44- Clinical Trial Not Allowed) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Support for Small Business Innovation Research to Develop New Open and Closed-Loop Automated Technologies for Better Type 1 Diabetes Therapy and Monitoring (SBIR) (R43/R44- Clinical Trial Not Allowed): The goal of this Funding Opportunity Announcement (FOA) is to stimulate bioengineers, physiologists, bio-behavioral researchers, and designers in academic centers and small businesses to develop new approaches to create devices/components with enhanced accuracy and less patient burden that will represent real advancements regarding safety and effectiveness of glucose control technologies including open and closed loop hormone replacement systems.
Federal Grant Title: Support for Small Business Innovation Research to Develop New Open and Closed-Loop Automated Technologies for Better Type 1 Diabetes Therapy and Monitoring (SBIR) (R43/R44- Clinical Trial Not Allowed)
Federal Agency Name: National Institutes of Health (HHS-NIH11)
Grant Categories: Food and Nutrition Health
Type of Opportunity: Discretionary
Funding Opportunity Number: RFA-DK-17-029
Type of Funding: Grant
CFDA Numbers: 93.847
CFDA Descriptions: Information not provided
Current Application Deadline: March 21st, 2018
Original Application Deadline: March 21st, 2018
Posted Date: December 21st, 2017
Creation Date: December 21st, 2017
Archive Date: April 26th, 2018
Total Program Funding:
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching: No
Last Updated: December 21st, 2017
Applicants Eligible for this Grant
Small businesses
Additional Information on Eligibility
Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, may be allowed. See the funding opportunity announcements for eligibility details
Link to Full Grant Announcement
http://grants.nih.gov/grants/guide/rfa-files/RFA-DK-17-029.html
Grant Announcement Contact
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV

If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
Similar Government Grants
Understanding Skeletal Effects of Type 1 Diabetes (R01 Clinical Trial Optional)
Undergraduate Summer Research Education in Kidney, Urologic, and Hematologic Diseases (R25...
Pilot and Feasibility Clinical Research Grants in Kidney Diseases (R21 Clinical Trial Opti...
Pilot and Feasibility Clinical Research Grants in Urologic Disorders (R21 Clinical Trial O...
Mechanisms Underlying the Contribution of Type 1 Diabetes Disease-associated Variants (R01...
Proteomic and Metabolomic Approaches to Diagnose Diabetes and Pre-Diabetes
Molecular Therapy Core Centers
Pilot and Feasibility Program in Human Islet Biology
More Grants from the National Institutes of Health
NIOSH Exploratory/Developmental Grant Program (R21)
K01 Mentored Research Scientist Development Award
NIOSH Small Research Grant Program
Cancer Prevention, Diagnosis, and Treatment Technologies for Low-Resource Settings (R43/R4...
Cancer Prevention, Diagnosis, and Treatment Technologies for Low-Resource Settings (R41/R4...

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2018 FederalGrants.com